Department of Anesthesia, Department of Medicine, and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Mayo Clin Proc. 2013 Aug;88(8):871-83. doi: 10.1016/j.mayocp.2013.04.001.
The concept of the heart as a terminally differentiated organ incapable of replacing damaged myocytes has been at the center of cardiovascular research and therapeutic development for the past 50 years. The progressive decline in myocyte number as a function of age and the formation of scarred tissue after myocardial infarction have been interpreted as irrefutable proofs of the postmitotic characteristic of the heart. However, emerging evidence supports a more dynamic view of the heart in which cell death and renewal are vital components of the remodeling process that governs cardiac homeostasis, aging, and disease. The identification of dividing myocytes in the adult and senescent heart raises the important question concerning the origin of these newly formed cells. In vitro and in vivo findings strongly suggest that replicating myocytes derive from lineage determination of resident primitive cells, supporting the notion that cardiomyogenesis is controlled by activation and differentiation of a stem cell compartment. It is the current view that the myocardium is an organ permissive of tissue regeneration mediated by exogenous and endogenous progenitor cells.
在过去的 50 年里,心脏作为一个终末分化的器官,不能替换受损的心肌细胞的概念一直是心血管研究和治疗发展的核心。心肌细胞数量随年龄的增长而逐渐减少,心肌梗死后形成瘢痕组织,这些都被解释为心脏有丝分裂后特征的不容置疑的证据。然而,新出现的证据支持一种更具活力的心脏观点,即细胞死亡和更新是调节心脏重塑过程的重要组成部分,而心脏重塑过程则控制着心脏的稳态、衰老和疾病。在成年和衰老的心脏中发现有丝分裂的心肌细胞,这就提出了一个重要的问题,即这些新形成的细胞的来源。体外和体内的发现强烈表明,复制的心肌细胞来源于驻留原始细胞的谱系决定,这支持了心肌发生是由干细胞区室的激活和分化控制的观点。目前的观点认为,心肌是一种允许通过外源性和内源性祖细胞介导的组织再生的器官。